ENLV

Enlivex Therapeutics Stock Price

5.42
0.23 (4.43%)
Upgrade to Real-Time
Regular Market
5.42
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Enlivex Therapeutics Ltd ENLV NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.23 4.43% 5.42 5.15 5.47 5.17 5.19 12:54:52
Bid Price Ask Price Spread Spread % News
5.38 5.42 0.04 0.74% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
395 84,691 $ 5.31 $ 449,785 94,499 3.59 - 44.90
Last Trade Time Type Quantity Stock Price Currency
12:54:52 100 $ 5.42 USD

Enlivex Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 72.11M 13.43M 5.72M $ - $ - -6.78 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Enlivex Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ENLV Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.516.575.045.3361,154-0.09-1.63%
1 Month5.306.595.045.5563,5910.122.26%
3 Months5.186.784.855.69113,9690.244.63%
6 Months8.4016.993.596.25141,608-2.98-35.48%
1 Year25.4644.903.597.2490,352-20.04-78.71%
3 Years2.7144.900.77383.94102,8302.71100.0%
5 Years28.5044.900.77384.9170,770-23.08-80.98%

Enlivex Therapeutics Description

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.


Your Recent History
NASDAQ
ENLV
Enlivex Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.